SynthesisFrontiers in immunology2026

Overall survival with immune checkpoint inhibitors across treatment settings and clinical and PD-L1-defined subgroups in advanced esophageal squamous cell carcinoma: a systematic review and meta-analysis of randomized trials.

Bing Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.